Position in ARVN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$800,692
-$1,393,135 QoQ
Shares Held
75,537
-59.2% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Voleon Capital Management LP holds $146,865,287 across 62 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
84,433 | $20,666,665 | |
| 2 | EXEL |
Exelixis, Inc.
|
251,462 | $13,682,047 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
674,245 | $12,116,182 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
133,952 | $9,976,744 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
82,877 | $9,702,410 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
145,655 | $8,274,660 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
91,926 | $7,992,965 | |
| 8 | INBX |
Inhibrx Biosciences, Inc.
|
58,358 | $5,529,420 |
All Filings in ARVN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $800,692 | 75,537 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,193,827 | 184,977 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,295,517 | 152,056 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||